1. Measurement of Short Term Health Effects in Economic Evaluations

   • Ann M. Holmes

   Current Opinion 17 September 2012 Pages: 171 - 174

2. Pharmacoeconomics in the New Millennium

   • Rob Thwaites
   • Raymond J. Townsend

   Current Opinion 17 September 2012 Pages: 175 - 180

3. A Prospective View on European Pharmaceutical Research and Development

   • Panos Kanavos

   Leading Article 17 September 2012 Pages: 181 - 190

4. Chlamydia trachomatis in Adolescents and Adults

   • Carlo A. Marra
   • David M. Patrick
   • Fawziah Marra

   Review Article 17 September 2012 Pages: 191 - 222

5. The Effects of Acquisition Cost and Budget-Based Compensation on the Attitudes of Pharmacy Directors Toward the Adoption of a Cost-Effective New Drug

   • Mick Kolassa
   • Mickey C. Smith
   • William F. Shughart

   Original Research Article 17 September 2012 Pages: 223 - 230

6. Cost-Benefit Analysis of Risperidone and Clozapine in the Treatment of Schizophrenia in Israel

   • Gary Ginsberg
   • Segev Shani
   • Boaz Lev

   Original Research Article 17 September 2012 Pages: 231 - 241

7. Pharmacoeconomic Analysis of Oral Antifungal Therapies Used to Treat Dermatophyte Onychomycosis of the Toenails

   • Aditya K. Gupta

   Original Research Article 17 September 2012 Pages: 243 - 256

8. Cost of an Outbreak of Hepatitis A in Puglia, Italy

   • Carlo Lucioni
   • Vincenzo Cipriani
   • Michele Panunzio

   Original Research Article 17 September 2012 Pages: 257 - 266